Abstract

Abstract BACKGROUND: The relevance of some plasma-based medicinal products, especially platelet concentrates in modern medical care, is confirmed by their inclusion in the World Health Organization Essential Medicines. Therefore, this study characterized bacterial contamination in blood donor’s platelet concentrates in Lagos State. METHODS: A total number of 10 units of screened blood were collected and platelet concentrates were serially sampled following an aseptic procedure and stored for a period of 8 days (day 1 to day 8). The samples were incubated at 37°C on a daily basis for 7 days in brain–heart infusion growth medium and thioglycolate broth, respectively. The identities of the isolated organisms were determined by following standard microbiological techniques. The resistance pattern of isolates to selected antimicrobial agents was also determined by disc diffusion method. RESULTS: The results obtained showed that the overall prevalence of bacterial contamination in platelet concentrates stored at room temperature was 20% (2/10), with the growth on the 1st day of culture. The pattern of the bacterial isolates was Staphylococcus aureus – 10% (1/10) and Staphylococcus epidermidis – 10% (1/10) from 10 platelet concentrates with agitation for 8 days with no evidence of co-bacterial contamination. The resistance pattern of the bacterial isolates to different selected antibiotics ranged from 50% to 100%. There was no significant difference in P value obtained in the comparative analysis of the proportions of S. aureus and S. epidermidis in platelet concentrates (P = 1.000; P > 0.05). The findings of this study also confirmed the presence of multidrug-resistant Gram-positive bacteria in the blood component for transfusion studied in Lagos; the organisms isolated were S. aureus and S. epidermidis. The resistance pattern of the bacteria to the antibiotics ranged from 50% to 100%. CONCLUSION: This work revealed evidence of bacterial contamination in platelet concentrates prepared for transfusion with an overall bacterial contamination of 20% (S. aureus – 10%; S. epidermidis – 10%) with no evidence of co-bacterial contamination but with evidence of S. aureus and S. epidermidis multidrug resistance, hence the need for proper storage and screening of platelet concentrates for bacterial contamination before transfusion to avoid platelet aggregation that may lead to fatal complications in the recipient.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call